BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33069869)

  • 1. Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice.
    Lee MT; Chen YH; Mackie K; Chiou LC
    J Pain; 2021 Mar; 22(3):300-312. PubMed ID: 33069869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray.
    Chen YH; Lee HJ; Lee MT; Wu YT; Lee YH; Hwang LL; Hung MS; Zimmer A; Mackie K; Chiou LC
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10720-E10729. PubMed ID: 30348772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
    Lee HJ; Chang LY; Ho YC; Teng SF; Hwang LL; Mackie K; Chiou LC
    Neuropharmacology; 2016 Jun; 105():577-586. PubMed ID: 26907809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
    Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
    Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of the nitric oxide-cGMP-PKG-JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain.
    Hervera A; Leánez S; Pol O
    Eur J Pharmacol; 2012 Jun; 685(1-3):42-51. PubMed ID: 22546233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
    Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of peripheral nociceptive signal input relieves the formation of spinal central sensitization and retains morphine efficacy in a neuropathic pain rat model.
    Zhong W; Ma X; Xing Y; Kim DK; Wang A; Jiang W; Xu T
    Neurosci Lett; 2020 Jan; 716():134643. PubMed ID: 31760085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid and cannabinoid synergy in a mouse neuropathic pain model.
    Kazantzis NP; Casey SL; Seow PW; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2016 Aug; 173(16):2521-31. PubMed ID: 27278681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-Acupoint Electroacupuncture Induces Better Analgesia via Activating the Endocannabinoid System in the Spinal Cord.
    Jiang Z; Li Y; Wang Q; Fang Z; Deng J; Zhang X; Shen B; Wu Z; Yang Q; Xiong L
    Neural Plast; 2022; 2022():7670629. PubMed ID: 36160326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β and opioid receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under pathological pain conditions.
    Lantero A; Tramullas M; Pílar-Cuellar F; Valdizán E; Santillán R; Roques BP; Hurlé MA
    J Neurosci; 2014 Apr; 34(15):5385-95. PubMed ID: 24719115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalating morphine dosage fails to elicit conditioned analgesia in a preclinical chronic neuropathic pain model.
    Boorman DC; Keay KA
    Behav Pharmacol; 2021 Sep; 32(6):479-486. PubMed ID: 34320522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
    Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K
    J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T; Sutak M; Jhamandas K
    Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of electroacupuncture at "Neiguan" (PC6) on pain and brain orexin 1 receptor in mice with inflammatory pain.
    Ma NQ; Yang JL; Shi JJ; Jiang MJ; Peng R; Li Y; Lu SF
    Zhen Ci Yan Jiu; 2024 May; 49(5):441-447. PubMed ID: 38764114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
    Becker A; Geisslinger G; Murín R; Grecksch G; Höllt V; Zimmer A; Schröder H
    Naunyn Schmiedebergs Arch Pharmacol; 2013 May; 386(5):369-82. PubMed ID: 23371449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB
    Chen X; Cowan A; Inan S; Geller EB; Meissler JJ; Rawls SM; Tallarida RJ; Tallarida CS; Watson MN; Adler MW; Eisenstein TK
    Br J Pharmacol; 2019 Sep; 176(17):3378-3389. PubMed ID: 31218677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.